Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews...
    • Mechanisms Underlying the Metabolic Syndrome (Oct 2019)
    • Reparative Immunology (Jul 2019)
    • Allergy (Apr 2019)
    • Biology of familial cancer predisposition syndromes (Feb 2019)
    • Mitochondrial dysfunction in disease (Aug 2018)
    • Lipid mediators of disease (Jul 2018)
    • Cellular senescence in human disease (Apr 2018)
    • View all review series...
  • Collections
    • Recently published
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Scientific Show Stoppers
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • About
  • Editors
  • Consulting Editors
  • For authors
  • Current issue
  • Past issues
  • By specialty
  • Subscribe
  • Alerts
  • Advertise
  • Contact
  • Conversations with Giants in Medicine
  • Author's Takes
  • Recently published
  • Brief Reports
  • Technical Advances
  • Commentaries
  • Editorials
  • Hindsight
  • Review series
  • Reviews
  • The Attending Physician
  • First Author Perspectives
  • Scientific Show Stoppers
  • Top read articles
  • Concise Communication
Top
  • View PDF
  • Download citation information
  • Send a letter
  • Terms of use
  • Standard abbreviations
  • Article usage
  • Citations to this article
  • Share this article
  • Need Help? E-mail the JCI
  • Top
  • Version history

Advertisement

Research Article Free access | 10.1172/JCI116387

Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women.

P Szulc, M C Chapuy, P J Meunier, and P D Delmas

Institut National de la Santé et de la Recherche Médicale (INSERM) Unit 234, Hôpital Edouard Herriot, Lyon, France.

Find articles by Szulc, P. in: JCI | PubMed | Google Scholar

Institut National de la Santé et de la Recherche Médicale (INSERM) Unit 234, Hôpital Edouard Herriot, Lyon, France.

Find articles by Chapuy, M. in: JCI | PubMed | Google Scholar

Institut National de la Santé et de la Recherche Médicale (INSERM) Unit 234, Hôpital Edouard Herriot, Lyon, France.

Find articles by Meunier, P. in: JCI | PubMed | Google Scholar

Institut National de la Santé et de la Recherche Médicale (INSERM) Unit 234, Hôpital Edouard Herriot, Lyon, France.

Find articles by Delmas, P. in: JCI | PubMed | Google Scholar

First published April 1, 1993 - More info

Published in Volume 91, Issue 4 on April 1, 1993
J Clin Invest. 1993;91(4):1769–1774. https://doi.org/10.1172/JCI116387.
© 1993 The American Society for Clinical Investigation
First published April 1, 1993 - Version history
Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 1769
page 1769
icon of scanned page 1770
page 1770
icon of scanned page 1771
page 1771
icon of scanned page 1772
page 1772
icon of scanned page 1773
page 1773
icon of scanned page 1774
page 1774
Version history
  • Version 1 (April 1, 1993): No description

Article tools

  • View PDF
  • Download citation information
  • Send a letter
  • Terms of use
  • Standard abbreviations
  • Article usage
  • Citations to this article
  • Share this article
  • Need Help? E-mail the JCI

Go to:

  • Top
  • Version history
Advertisement
Advertisement
Follow JCI:
Copyright © 2019 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts